Institutional members access full text with Ovid®

Parenteral nutrition in the critically ill

Gunst, Jan; Van den Berghe, Greet

Current Opinion in Critical Care: April 2017 - Volume 23 - Issue 2 - p 149–158
doi: 10.1097/MCC.0000000000000385
GASTROINTESTINAL SYSTEM: Edited by W. Joost Wiersinga

Purpose of review: Feeding guidelines have recommended early, full nutritional support in critically ill patients to prevent hypercatabolism and muscle weakness. Early enteral nutrition was suggested to be superior to early parenteral nutrition. When enteral nutrition fails to meet nutritional target, it was recommended to administer supplemental parenteral nutrition, albeit with a varying starting point. Sufficient amounts of amino acids were recommended, with addition of glutamine in subgroups. Recently, several large randomized controlled trials (RCTs) have yielded important new insights. This review summarizes recent evidence with regard to the indication, timing, and dosing of parenteral nutrition in critically ill patients.

Recent findings: One large RCT revealed no difference between early enteral nutrition and early parenteral nutrition. Two large multicenter RCTs showed harm by early supplementation of insufficient enteral nutrition with parenteral nutrition, which could be explained by feeding-induced suppression of autophagy. Several RCTs found either no benefit or harm with a higher amino acid or caloric intake, as well as harm by administration of glutamine.

Summary: Although unanswered questions remain, current evidence supports accepting low macronutrient intake during the acute phase of critical illness and does not support use of early parenteral nutrition. The timing when parenteral nutrition can be initiated safely and effectively is unclear.

Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Correspondence to Professor Greet Van den Berghe, MD, PhD, Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium. Tel: +32 16 344021; fax: +32 16 344015; e-mail: greet.vandenberghe@kuleuven.be.

Copyright © 2017 YEAR Wolters Kluwer Health, Inc. All rights reserved.